RSS-0393

N/A

Report date: 2026/04/28 20:00:22
NME

Base Information

Drug NameRSS-0393
Drug Alias NameRSS0393RSS-0393
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsPlaque psoriasisPsoriasisDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesReistone Biopharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Hengrui Medicine Co LtdReistone Biopharma Co LtdReistone Biopharma Company Ltd
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisPsoriasisDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A